ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Potter New AACI President, Sartorlli President Elect; NCI Staffers Get NIH Director’s Award

July 18, 1986

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991

Food & Water Inc. Launches ‘Cancer Prevention Campaign’

May 1, 1992

Univ. Of Pittsburg distances Itself From Fisher

June 24, 1994

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998